Literature DB >> 14557907

Early postnatal corticosterone administration regulates neurotrophins and their receptors in septum and hippocampus of the rat.

Thomas Roskoden1, Uwe Otten, Herbert Schwegler.   

Abstract

The principal glucocorticoid in rats, corticosterone, interacts with neurons in the limbic system and leads to morphological and behavioral changes. Putative corticosterone-triggered mediators are neurotrophins. In the present study we investigated the effects of early postnatal corticosterone treatment in rats on neurotrophic factors of the nerve growth factor (NGF) family and their receptors. Newborn rats were treated with corticosterone-containing polymers until postnatal day 12. The mRNA and protein levels of the neurotrophins of the NGF family (NGF, BDNF, NT-3 and NT-4/5) and their receptors (trkA, trkB, trkC and p75) were quantified in septum and hippocampus using RT-PCR. In the septal region, we found an unchanged mRNA expression after corticosterone treatment, whereas in the hippocampus there was a general increase in mRNA. Particularly, the gene expression of NGF, NT-3, and the high affinity receptors trkA, trkB and trkC increased significantly. Quantification of the neurotrophin protein levels using an ELISA revealed significant treatment effects for NGF and NT-4/5 in the hippocampus. The present study of corticosterone treatment in young rats demonstrates interactions of steroid hormones with neurotrophic factors and their receptors in the septo-hippocampal system during the first two postnatal weeks.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557907     DOI: 10.1007/s00221-003-1656-5

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  45 in total

Review 1.  Stress and hippocampal plasticity.

Authors:  B S McEwen
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

2.  Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons.

Authors:  C S Woolley; E Gould; B S McEwen
Journal:  Brain Res       Date:  1990-10-29       Impact factor: 3.252

Review 3.  Corticosteroids in the brain. Cellular and molecular actions.

Authors:  M Joëls; E Vreugdenhil
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

4.  Small drug sample fabrication of controlled release polymers using the microextrusion method.

Authors:  K L Haik-Creguer; G L Dunbar; B A Sabel; U Schroeder
Journal:  J Neurosci Methods       Date:  1998-03-13       Impact factor: 2.390

Review 5.  Neurosteroids and GABAA receptor function.

Authors:  J J Lambert; D Belelli; C Hill-Venning; J A Peters
Journal:  Trends Pharmacol Sci       Date:  1995-09       Impact factor: 14.819

6.  Expression of functional trk protooncogene in human monocytes.

Authors:  P B Ehrhard; U Ganter; A Stalder; J Bauer; U Otten
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

7.  Modulation of mRNA expression of the neurotrophins of the nerve growth factor family and their receptors in the septum and hippocampus of rats after transient postnatal thyroxine treatment. I. Expression of nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin 4 mRNA.

Authors:  H G Lüesse; T Roskoden; R Linke; U Otten; K Heese; H Schwegler
Journal:  Exp Brain Res       Date:  1998-03       Impact factor: 1.972

8.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

9.  Transient postnatal thyroxine treatment leads to an increased number of cholinergic neurons in the medial septum and to a higher density of cholinergic fibers in hippocampal CA3 in rats.

Authors:  H Schwegler
Journal:  Neurosci Lett       Date:  1995-10-06       Impact factor: 3.046

10.  [The ontogenetic development of pyramidal neurons in the hippocampus (CA1) of the rat].

Authors:  H G Minkwitz; L Holz
Journal:  J Hirnforsch       Date:  1975
View more
  7 in total

1.  Association of antenatal steroid use with cord blood immune biomarkers in preterm births.

Authors:  Praveen Kumar; Scott A Venners; Lingling Fu; Colleen Pearson; Katherin Ortiz; Xiaobin Wang
Journal:  Early Hum Dev       Date:  2011-05-14       Impact factor: 2.079

2.  (+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats.

Authors:  Curtis E Grace; Tori L Schaefer; Nicole R Herring; Matthew R Skelton; Anne E McCrea; Charles V Vorhees; Michael T Williams
Journal:  Synapse       Date:  2008-02       Impact factor: 2.562

3.  Early repeated maternal separation induces alterations of hippocampus reelin expression in rats.

Authors:  Jianlong Zhang; Lina Qin; Hu Zhao
Journal:  J Biosci       Date:  2013-03       Impact factor: 1.826

Review 4.  Developmental effects of 3,4-methylenedioxymethamphetamine: a review.

Authors:  Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Behav Pharmacol       Date:  2008-03       Impact factor: 2.293

5.  Early maternal separation alters the response to traumatization: resulting in increased levels of hippocampal neurotrophic factors.

Authors:  Jacqueline Faure; Joachim D K Uys; Lelanie Marais; Dan J Stein; Willie M U Daniels
Journal:  Metab Brain Dis       Date:  2007-04-29       Impact factor: 3.584

6.  Neonatal (+)-methamphetamine increases brain derived neurotrophic factor, but not nerve growth factor, during treatment and results in long-term spatial learning deficits.

Authors:  Matthew R Skelton; Michael T Williams; Tori L Schaefer; Charles V Vorhees
Journal:  Psychoneuroendocrinology       Date:  2007-07-02       Impact factor: 4.905

7.  Cholinergic Degeneration and Alterations in the TrkA and p75NTR Balance as a Result of Pro-NGF Injection into Aged Rats.

Authors:  Ashley M Fortress; Mona Buhusi; Kris L Helke; Ann-Charlotte E Granholm
Journal:  J Aging Res       Date:  2011-07-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.